MCID: PRM155
MIFTS: 39

Primary Cutaneous Anaplastic Large Cell Lymphoma malady

Categories: Skin diseases, Blood diseases, Rare diseases, Immune diseases

Aliases & Classifications for Primary Cutaneous Anaplastic Large Cell Lymphoma

Aliases & Descriptions for Primary Cutaneous Anaplastic Large Cell Lymphoma:

Name: Primary Cutaneous Anaplastic Large Cell Lymphoma 56
Lymphoma, Primary Cutaneous Anaplastic Large Cell 69
Regressive Atypical Histiocytosis 56
Primary C-Alcl 56

Characteristics:

Orphanet epidemiological data:

56
primary cutaneous anaplastic large cell lymphoma
Age of onset: Adolescent,Adult,Childhood; Age of death: adult;

Classifications:



External Ids:

Orphanet 56 ORPHA300865
UMLS via Orphanet 70 C1301362 C1698767
ICD10 via Orphanet 34 C86.6

Summaries for Primary Cutaneous Anaplastic Large Cell Lymphoma

MalaCards based summary : Primary Cutaneous Anaplastic Large Cell Lymphoma, also known as lymphoma, primary cutaneous anaplastic large cell, is related to anaplastic large cell lymphoma and lymphoma. An important gene associated with Primary Cutaneous Anaplastic Large Cell Lymphoma is NPM1 (Nucleophosmin), and among its related pathways/superpathways are NF-kappaB Signaling and Tyrosine Kinases / Adaptors. The drugs Etoposide and Methotrexate have been mentioned in the context of this disorder. Affiliated tissues include skin, t cells and neutrophil, and related phenotype is neoplasm.

Related Diseases for Primary Cutaneous Anaplastic Large Cell Lymphoma

Diseases related to Primary Cutaneous Anaplastic Large Cell Lymphoma via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 66)
id Related Disease Score Top Affiliating Genes
1 anaplastic large cell lymphoma 10.8
2 lymphoma 10.8
3 lymphomatoid papulosis 10.3
4 subacute delirium 10.2 ALK PTPRC
5 mycosis fungoides 10.2
6 neurofibromatosis 10.1 NPM1 PTPRC
7 malignant glioma 10.1 GZMB TIA1
8 polydactyly cleft lip palate psychomotor retardation 10.1 MUC1 PTPRC
9 alström syndrome 10.1 GZMB TIA1
10 skeletal muscle cancer 10.1 GZMB TIA1
11 tibial adamantinoma 10.1 GZMB TIA1
12 appendix mucinous cystadenocarcinoma 10.1 MUC1 PTPRC
13 collagen type iii glomerulopathy 10.1 GZMB TIA1
14 embryonal testis carcinoma 10.1 MUC1 PTPRC
15 fibrosclerosis of breast 10.1 GZMB TIA1
16 uterine ligament endometrioid adenocarcinoma 10.1 GZMB TIA1
17 linear lichen planus 10.1 GZMB TIA1
18 omodysplasia 2 10.1 MUC1 PTPRC
19 congenital muscular dystrophy with hyperlaxity 10.1 MUC1 PTPRC
20 malignant teratoma 10.1 GZMB TIA1
21 penile disease 10.1 ALK IRF4 PTPRC
22 cerebral lipidosis 10.1 GZMB TIA1
23 allergic contact dermatitis 10.1 ALK MUC1
24 childhood immature teratoma of ovary 10.1 GZMB TIA1
25 lung benign neoplasm 10.0 MUC1 PTPRC
26 plasmodium ovale malaria 10.0 GZMB TIA1
27 complication after organ transplantation 10.0 ALK MUC1 NPM1
28 desmoid tumor 10.0 MUC1 PTPRC
29 mixed cell type cancer 10.0 GZMB TIA1
30 mongolian spot 10.0 ALK MUC1
31 burn scar 10.0
32 pneumonia 10.0
33 burns 10.0
34 squamous cell carcinoma 10.0
35 human herpesvirus 8 10.0
36 post-transplant lymphoproliferative disease 10.0 ALK GZMB TIA1
37 diabetes persistent mullerian ducts 10.0 MUC1 PTPRC
38 marantic endocarditis 10.0 ALK NPM1 TIA1
39 hyperaldosteronism, familial, type ii 9.9 GZMB TIA1
40 estrogen-receptor negative breast cancer 9.9 ALK NPM1 PTPRC TIA1
41 histiocytosis 9.9
42 kidney benign neoplasm 9.9 MUC1 PTPRC
43 hepatitis c virus 9.9
44 atopic dermatitis 9.9
45 cerebritis 9.9
46 myeloid leukemia 9.9
47 hemophagocytic lymphohistiocytosis 9.9
48 hepatitis 9.9
49 pyogenic granuloma 9.9
50 leukemia 9.9

Graphical network of the top 20 diseases related to Primary Cutaneous Anaplastic Large Cell Lymphoma:



Diseases related to Primary Cutaneous Anaplastic Large Cell Lymphoma

Symptoms & Phenotypes for Primary Cutaneous Anaplastic Large Cell Lymphoma

MGI Mouse Phenotypes related to Primary Cutaneous Anaplastic Large Cell Lymphoma:

44
id Description MGI Source Accession Score Top Affiliating Genes
1 neoplasm MP:0002006 8.92 ALK IRF4 NPM1 PTPRC

Drugs & Therapeutics for Primary Cutaneous Anaplastic Large Cell Lymphoma

Drugs for Primary Cutaneous Anaplastic Large Cell Lymphoma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 328)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Etoposide Approved Phase 2, Phase 3,Phase 1,Early Phase 1 33419-42-0 36462
2
Methotrexate Approved Phase 3,Phase 2,Phase 1 1959-05-2, 59-05-2 126941
3
Melphalan Approved Phase 2, Phase 3,Phase 1 148-82-3 4053 460612
4
Ciprofloxacin Approved, Investigational Phase 3 85721-33-1 2764
5
Ketamine Approved, Vet_approved Phase 3 6740-88-1 3821
6
Ofloxacin Approved Phase 3 82419-36-1 4583
7
Amoxicillin Approved, Vet_approved Phase 3 26787-78-0 33613 2171
8
Thiotepa Approved Phase 2, Phase 3 52-24-4 5453
9
Cefepime Approved Phase 3 88040-23-7 5479537
10
Levofloxacin Approved, Investigational Phase 3 100986-85-4 149096
11
Heparin Approved, Investigational Phase 3 9005-49-6 772 46507594
12
Carboplatin Approved Phase 2, Phase 3,Phase 1 41575-94-4 10339178 498142 38904
13
Cyclophosphamide Approved, Investigational Phase 2, Phase 3,Phase 1,Early Phase 1 50-18-0, 6055-19-2 2907
14
Iron Approved Phase 3,Phase 1,Phase 2 7439-89-6 23925
15
Morphine Approved, Investigational Phase 3 57-27-2 5288826
16
Fludarabine Approved Phase 2, Phase 3, Phase 1 21679-14-1, 75607-67-9 30751
17
Busulfan Approved, Investigational Phase 2, Phase 3,Phase 1,Early Phase 1 55-98-1 2478
18
Amphotericin B Approved, Investigational Phase 3 1397-89-3 14956 5280965
19
Miconazole Approved, Investigational, Vet_approved Phase 3,Phase 1,Phase 2 22916-47-8 4189
20
Ondansetron Approved Phase 3 99614-02-5 4595
21
Bexarotene Approved, Investigational Phase 3,Phase 1 153559-49-0 82146
22
Fentanyl Approved, Illicit, Investigational, Vet_approved Phase 3 437-38-7 3345
23
Dextromethorphan Approved Phase 3 125-71-3 5360696 5362449
24
Dalteparin Approved Phase 3 9041-08-1
25
Darbepoetin alfa Approved, Investigational Phase 3,Phase 2 11096-26-7, 209810-58-2
26
Caspofungin Approved Phase 3,Phase 2 179463-17-3, 162808-62-0 468682 2826718
27
Guaifenesin Approved, Vet_approved Phase 3,Phase 2 93-14-1 3516
28
leucovorin Approved, Nutraceutical Phase 3,Phase 2,Phase 1,Early Phase 1 58-05-9 54575, 6560146 143
29
Folic Acid Approved, Nutraceutical, Vet_approved Phase 3,Phase 2,Phase 1,Early Phase 1 59-30-3 6037
30
Ginseng Approved, Nutraceutical Phase 3 50647-08-0
31 Clavulanic Acid Phase 3
32 Analgesics Phase 3,Phase 1
33 Alkylating Agents Phase 2, Phase 3,Phase 1,Early Phase 1
34 Folic Acid Antagonists Phase 3,Phase 2,Phase 1,Early Phase 1
35 Neurotransmitter Agents Phase 3,Phase 1
36 Amoxicillin-Potassium Clavulanate Combination Phase 3
37 Cytochrome P-450 CYP1A2 Inhibitors Phase 3
38 Cytochrome P-450 Enzyme Inhibitors Phase 3,Phase 2,Phase 1
39 Topoisomerase Inhibitors Phase 3,Phase 2,Phase 1,Early Phase 1
40 Nucleic Acid Synthesis Inhibitors Phase 3,Phase 2,Phase 1,Early Phase 1
41 Dermatologic Agents Phase 3,Phase 2,Phase 1
42 Anesthetics Phase 3
43 Anesthetics, Dissociative Phase 3
44 Anesthetics, General Phase 3
45 Anesthetics, Intravenous Phase 3
46 Peripheral Nervous System Agents Phase 3,Phase 1,Phase 2
47 Vitamin B Complex Phase 3,Phase 2,Phase 1,Early Phase 1
48 Anti-Bacterial Agents Phase 3,Phase 1,Phase 2,Early Phase 1
49 Etoposide phosphate Phase 2, Phase 3,Phase 1,Early Phase 1
50 Immunoglobulins Phase 3,Phase 1,Phase 2

Interventional clinical trials:

(show top 50) (show all 200)
id Name Status NCT ID Phase
1 Levofloxacin Compared With Cefepime in Treating Cancer Patients With Fever and Neutropenia Unknown status NCT00020865 Phase 3
2 Early Hospital Discharge or Standard Inpatient Care in Cancer Patients Receiving Antibiotics for Febrile Neutropenia Unknown status NCT00445497 Phase 3
3 Ketamine Hydrochloride and Best Pain Management in Treating Cancer Patients With Neuropathic Pain Unknown status NCT01316744 Phase 3
4 Levofloxacin to Prevent Infection Following Chemotherapy in Treating Patients With Solid Tumors or Lymphoma Completed NCT00005590 Phase 3
5 Personalized Information or Basic Information in Helping Patients Make Decisions About Participating in a Clinical Trial Completed NCT00750009 Phase 3
6 Opioid Titration Order Sheet or Standard Care in Treating Patients With Cancer Pain Completed NCT00666211 Phase 3
7 American Ginseng in Treating Patients With Fatigue Caused by Cancer Completed NCT00719563 Phase 3
8 St. John's Wort in Relieving Fatigue in Patients Undergoing Chemotherapy or Hormone Therapy for Cancer Completed NCT00005805 Phase 3
9 Ondansetron in Treating Patients With Advanced Cancer and Chronic Nausea and Vomiting Not Caused by Cancer Treatment Completed NCT00006348 Phase 3
10 Dalteparin to Prevent Complications in Cancer Patients Receiving Chemotherapy Through a Catheter Completed NCT00006083 Phase 3
11 Darbepoetin Alfa Compared With Epoetin Alfa in Treating Anemia in Patients Receiving Chemotherapy for Cancer Completed NCT00070382 Phase 3
12 Treatment for Chronic Pain in Patients With Advanced Cancer Completed NCT00003687 Phase 3
13 Darbepoetin Alfa With or Without Iron in Treating Anemia Caused By Chemotherapy in Patients With Cancer Completed NCT00661999 Phase 3
14 Caspofungin Acetate Compared With Amphotericin B Liposomal in Treating Patients With Persistent Fever and Neutropenia Following Cancer Treatment Completed NCT00008359 Phase 3
15 Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain Completed NCT00538850 Phase 3
16 Liposomal Amphotericin B in Treating Granulocytopenia and Persistent Unexplained Fever in Cancer Patients Completed NCT00003938 Phase 3
17 A Phase 3 Trial of Brentuximab Vedotin(SGN-35) Versus Physician's Choice (Methotrexate or Bexarotene) in Patients With CD30-Positive Cutaneous T-Cell Lymphoma Active, not recruiting NCT01578499 Phase 3
18 Combination Chemotherapy and Donor Stem Cell Transplant in Treating Patients With Aplastic Anemia or Hematologic Cancer Active, not recruiting NCT00003816 Phase 2, Phase 3
19 Brentuximab Vedotin + Rituximab as Frontline Therapy for Pts w/ CD30+ and/or EBV+ Lymphomas Unknown status NCT01805037 Phase 1, Phase 2
20 Lenalidomide as Maintenance Therapy After Combination Chemotherapy With or Without Rituximab and Stem Cell Transplant in Treating Patients With Persistent or Recurrent Non-Hodgkin Lymphoma That is Resistant to Chemotherapy Unknown status NCT01035463 Phase 1, Phase 2
21 Vaccine Therapy and GM-CSF in Treating Patients With CNS Lymphoma Unknown status NCT00621036 Phase 2
22 External-Beam Radiation Therapy With or Without Indinavir and Ritonavir in Treating Patients With Brain Metastases Unknown status NCT00637637 Phase 2
23 Study of SGN-30 (Anti-CD30 mAb) in Patients With Primary Cutaneous Anaplastic Large Cell Lymphoma Completed NCT00099255 Phase 2
24 RAD001 Combined With CHOP in Newly Diagnosed Peripheral T-cell Lymphomas Completed NCT01198665 Phase 1, Phase 2
25 Bendamustine Hydrochloride, Etoposide, Dexamethasone, and Filgrastim For Peripheral Blood Stem Cell Mobilization in Treating Patients With Refractory or Recurrent Lymphoma or Multiple Myeloma Completed NCT01110135 Phase 2
26 506U78 in Treating Patients With Lymphoma Completed NCT00005080 Phase 2
27 Iodine I 131 Tositumomab, Etoposide and Cyclophosphamide Followed by Autologous Stem Cell Transplant in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma Completed NCT00073918 Phase 2
28 Vorinostat, Rituximab, Ifosfamide, Carboplatin, and Etoposide in Treating Patients With Relapsed or Refractory Lymphoma or Previously Untreated T-Cell Non-Hodgkin Lymphoma or Mantle Cell Lymphoma Completed NCT00601718 Phase 1, Phase 2
29 Alemtuzumab, Fludarabine Phosphate, and Total-Body Irradiation Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer Completed NCT00118352 Phase 2
30 Cyclophosphamide for Prevention of Graft-Versus-Host Disease After Allogeneic Peripheral Blood Stem Cell Transplantation in Patients With Hematological Malignancies Completed NCT01427881 Phase 2
31 Veliparib, Bendamustine Hydrochloride, and Rituximab in Treating Patients With Relapsed or Refractory Lymphoma, Multiple Myeloma, or Solid Tumors Completed NCT01326702 Phase 1, Phase 2
32 Study of Akt Inhibitor MK2206 in Patients With Relapsed Lymphoma Completed NCT01258998 Phase 2
33 High-Dose Busulfan and High-Dose Cyclophosphamide Followed By Donor Bone Marrow Transplant in Treating Patients With Leukemia, Myelodysplastic Syndrome, Multiple Myeloma, or Recurrent Hodgkin or Non-Hodgkin Lymphoma Completed NCT01177371 Phase 2
34 Sorafenib Tosylate in Treating Patients With Recurrent Aggressive Non-Hodgkin's Lymphoma Completed NCT00131937 Phase 2
35 Voriconazole in Preventing Fungal Infections in Children With Neutropenia After Chemotherapy Completed NCT00066599 Phase 2
36 Donor Natural Killer Cells After Donor Stem Cell Transplant in Treating Patients With Advanced Cancer Completed NCT00823524 Phase 1, Phase 2
37 Sirolimus, Tacrolimus, and Antithymocyte Globulin in Preventing Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant For Hematological Cancer Completed NCT00589563 Phase 2
38 Gemcitabine Hydrochloride, Carboplatin, Dexamethasone, and Rituximab in Treating Patients With Previously Treated Lymphoid Malignancies Completed NCT00072514 Phase 2
39 Epoetin Alfa in Treating Patients With Anemia Who Are Undergoing Chemotherapy for Cancer Completed NCT00255749 Phase 2
40 Donor Umbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies Completed NCT01093586 Phase 2
41 Doxorubicin Hydrochloride Liposome and Bortezomib in Treating Patients With Refractory Hematologic Cancer or Malignant Solid Tumor or Metastatic Breast Cancer Completed NCT00237627 Phase 1, Phase 2
42 Epoetin Alfa or Darbepoetin Alfa in Treating Patients With Anemia Caused by Chemotherapy Completed NCT00416624 Phase 2
43 Peripheral Stem Cell Transplantation in Treating Patients With Breast Cancer or Hematologic Cancer Completed NCT00006225 Phase 1, Phase 2
44 Haploidentical Donor Bone Marrow Transplant in Treating Patients With High-Risk Hematologic Cancer Completed NCT00049504 Phase 2
45 Non-Ablative Allo HSCT For Hematologic Malignancies or SAA Completed NCT00006379 Phase 2
46 Beclomethasone in Treating Patients With Graft-Versus-Host Disease of the Esophagus, Stomach, Small Intestine, or Colon Completed NCT00010283 Phase 1, Phase 2
47 Bone Marrow Transplantation in Treating Patients With Hematologic Cancer Completed NCT00005804 Phase 2
48 Caspofungin Acetate in Treating Aspergillosis in Patients With Hematologic Cancer or in Patients Who Have Undergone a Stem Cell Transplant Completed NCT00110045 Phase 2
49 Busulfan, Fludarabine, and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Stem Cell Transplant for Hematologic Cancer Completed NCT00245037 Phase 1, Phase 2
50 Dasatinib for Modulating Immune System After Autologous Stem Cell Transplants for Multiple Myeloma, Non-Hodgkin, or Hodgkin Lymphoma Recruiting NCT01609816 Phase 1, Phase 2

Search NIH Clinical Center for Primary Cutaneous Anaplastic Large Cell Lymphoma

Genetic Tests for Primary Cutaneous Anaplastic Large Cell Lymphoma

Anatomical Context for Primary Cutaneous Anaplastic Large Cell Lymphoma

MalaCards organs/tissues related to Primary Cutaneous Anaplastic Large Cell Lymphoma:

39
Skin, T Cells, Neutrophil, Endothelial, B Cells, Myeloid

Publications for Primary Cutaneous Anaplastic Large Cell Lymphoma

Articles related to Primary Cutaneous Anaplastic Large Cell Lymphoma:

(show top 50) (show all 91)
id Title Authors Year
1
Disseminated CD8-positive, CD30-positive cutaneous lymphoproliferative eruption with overlapping features of mycosis fungoides and primary cutaneous anaplastic large cell lymphoma following remote solitary lesional presentation. ( 28497585 )
2017
2
Outcome of primary cutaneous anaplastic large cell lymphoma: a 20-year British Columbia Cancer Agency experience. ( 27766622 )
2017
3
Primary cutaneous anaplastic large-cell lymphoma: a case report. ( 26970422 )
2016
4
KIR3DL2 (CD158k) is a potential therapeutic target in primary cutaneous anaplastic large cell lymphoma. ( 27037558 )
2016
5
Primary Cutaneous Anaplastic Large-Cell Lymphoma With 6p25.3 Rearrangement in a Cardiac Transplant Recipient: A Case Report and Review of the Literature. ( 26863058 )
2016
6
Primary cutaneous anaplastic large cell lymphoma in a child simulating primary cutaneous Hodgkin's disease. ( 26728828 )
2016
7
Relapses of primary cutaneous anaplastic large-cell lymphoma in a female immunocompetent patient with persistent chlamydophila pneumoniae and human herpesvirus 8 infection. ( 27382410 )
2016
8
Low-dose radiotherapy for primary cutaneous anaplastic large-cell lymphoma while on low-dose methotrexate. ( 27874877 )
2016
9
Primary cutaneous anaplastic large cell lymphoma masquerading as large pyogenic granuloma. ( 27990392 )
2016
10
Synchronous Occurrence of Primary Cutaneous Anaplastic Large Cell Lymphoma and Squamous Cell Carcinoma. ( 27489433 )
2016
11
Multiple cytokine-producing primary cutaneous anaplastic large cell lymphoma. ( 27256346 )
2016
12
A case of CD4(+)/CD8(+) double-positive primary cutaneous anaplastic large cell lymphoma of the lip involving spontaneous regression after biopsy. ( 27694065 )
2016
13
Radiation Therapy for Primary Cutaneous Anaplastic Large Cell Lymphoma: An International Lymphoma Radiation Oncology Group Multi-institutional Experience. ( 27315663 )
2016
14
Treatment of primary cutaneous anaplastic large cell lymphoma with superficial x-rays. ( 25918620 )
2015
15
Primary Cutaneous Anaplastic Large Cell Lymphoma With Positive ALK Expression and a Rapidly Progressive Cutaneous Nodule. ( 25633507 )
2015
16
Assessment of diagnostic criteria between primary cutaneous anaplastic large cell lymphoma and CD30-rich transformed mycosis fungoides. A study of 66 cases. ( 25645336 )
2015
17
Primary cutaneous anaplastic large cell lymphoma in a child simulating primary cutaneous Hodgkin's disease. ( 26658398 )
2015
18
Occult Dermal Lymphatic Involvement Is Frequent in Primary Cutaneous Anaplastic Large Cell Lymphoma. ( 26381026 )
2015
19
Efficacy of Vinblastine in Primary Cutaneous Anaplastic Large Cell Lymphoma. ( 26108120 )
2015
20
A rare case of ALK negative CD30+ primary cutaneous anaplastic large cell lymphoma in a young adult. ( 26458652 )
2015
21
Primary cutaneous anaplastic large cell lymphoma in a patient receiving adalimumab. ( 27051683 )
2015
22
Composite Mantle Cell and Primary Cutaneous Anaplastic Large Cell Lymphoma: Case Report and Review of the Literature. ( 25374307 )
2014
23
Hemophagocytic lymphohistiocytosis in association with primary cutaneous anaplastic large cell lymphoma. ( 25405042 )
2014
24
Congenital Primary Cutaneous Anaplastic Large-Cell Lymphoma: A Case Report. ( 25365497 )
2014
25
Primary cutaneous anaplastic large cell lymphoma occurring in an atopic dermatitis patient: a case report with review of the literature with emphasis on their association. ( 24817972 )
2014
26
Keratosis lichenoides chronica in association with primary cutaneous anaplastic large cell lymphoma. ( 23228152 )
2014
27
Chronic Reparative Changes in Medium-Sized Vessels in a Case of Primary Cutaneous Anaplastic Large-Cell Lymphoma With Angioinvasive Features and Cytotoxic Phenotype: New Histopathological Findings in Line With Indolent Clinical Behavior. ( 25365499 )
2014
28
Comparison of CD163+ Macrophages and CD206+ Cells in Lesional Skin of CD30+ Lymphoproliferative Disorders of Lymphomatoid Papulosis and Primary Cutaneous Anaplastic Large-cell Lymphoma. ( 25403560 )
2014
29
Primary cutaneous anaplastic large cell lymphoma simulating an aggressive angiocentric T-cell lymphoma. ( 22458926 )
2013
30
Primary cutaneous anaplastic large-cell lymphoma. ( 21552098 )
2013
31
Remission of primary cutaneous anaplastic large cell lymphoma after a brief course of brentuximab vedotin. ( 23086510 )
2013
32
Primary Cutaneous Anaplastic Large Cell Lymphoma with Angioinvasive Features and Cytotoxic Phenotype: A Rare Lymphoma Variant within the Spectrum of CD30+ Lymphoproliferative Disorders. ( 24246691 )
2013
33
Detection of Chlamydophila pneumoniae and human herpesvirus 8 in primary cutaneous anaplastic large-cell lymphoma: a case report. ( 24099147 )
2013
34
Primary cutaneous anaplastic large-cell lymphoma - case report. ( 24346900 )
2013
35
Successful Treatment of Primary Cutaneous Anaplastic Large Cell Lymphoma with Intralesional Methotrexate Therapy. ( 24002114 )
2013
36
Granulocyte-colony stimulating factor-producing primary cutaneous anaplastic large cell lymphoma with cerebral metastasis. ( 22565644 )
2013
37
Primary cutaneous anaplastic large cell lymphoma arising from a burn scar. ( 22481116 )
2012
38
Anaplastic lymphoma kinase-positive primary cutaneous anaplastic large cell lymphoma--is it a new variant? ( 22565437 )
2012
39
Imprint cytology facilitating the diagnosis of primary cutaneous anaplastic large cell lymphoma of iliac fossa. ( 23326035 )
2012
40
Primary cutaneous anaplastic large-cell lymphoma occurring in a case of chronic myeloid leukemia in remission. ( 22775801 )
2012
41
Primary cutaneous anaplastic large-cell lymphoma of the eyelid. ( 21464784 )
2012
42
Primary cutaneous anaplastic large cell lymphoma shows a distinct miRNA expression profile and reveals differences from tumor-stage mycosis fungoides. ( 22776000 )
2012
43
A case of primary cutaneous anaplastic large cell lymphoma with prominent epidermotropism. ( 22450880 )
2012
44
HIV-associated primary cutaneous anaplastic large cell lymphoma: aA clinicopathological subset with more aggressive behavior? Case report and review of the literature. ( 23061973 )
2012
45
Syndrome of inappropriate antidiuretic hormone secretion associated with primary cutaneous anaplastic large cell lymphoma. ( 22409317 )
2012
46
Anaplastic lymphoma kinase expression in a recurrent primary cutaneous anaplastic large cell lymphoma with eventual systemic involvement. ( 21839333 )
2011
47
Primary cutaneous anaplastic large cell lymphoma with leg involvement: a case report and review of 11 cases. ( 21434982 )
2011
48
EORTC, ISCL, and USCLC consensus recommendations for the treatment of primary cutaneous CD30-positive lymphoproliferative disorders: lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma. ( 21841159 )
2011
49
Perils and pitfalls regarding differential diagnosis and treatment of primary cutaneous anaplastic large-cell lymphoma. ( 21552770 )
2011
50
CD8-positive primary cutaneous anaplastic large cell lymphoma presenting as multiple scrotal nodules and plaques. ( 21680287 )
2011

Variations for Primary Cutaneous Anaplastic Large Cell Lymphoma

Expression for Primary Cutaneous Anaplastic Large Cell Lymphoma

Search GEO for disease gene expression data for Primary Cutaneous Anaplastic Large Cell Lymphoma.

Pathways for Primary Cutaneous Anaplastic Large Cell Lymphoma

Pathways related to Primary Cutaneous Anaplastic Large Cell Lymphoma according to GeneCards Suite gene sharing:

id Super pathways Score Top Affiliating Genes
1 11.75 GZMB IRF4 PTPRC TYK2
2 11.59 ALK NPM1 TYK2
3 11.39 IRF4 MUC1 TYK2
4 11.17 PTPRC TYK2
5 11.02 PTPRC TYK2
6 10.91 TIA1 TYK2
7
Show member pathways
10.78 IRF4 TYK2
8 10.7 GZMB IRF4 PTPRC

GO Terms for Primary Cutaneous Anaplastic Large Cell Lymphoma

Biological processes related to Primary Cutaneous Anaplastic Large Cell Lymphoma according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 type I interferon signaling pathway GO:0060337 8.96 IRF4 TYK2
2 DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest GO:0006977 8.62 MUC1 NPM1

Sources for Primary Cutaneous Anaplastic Large Cell Lymphoma

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....